sRNAlytics
Latest round
- Seed
Last raised
- Nov 2017
Total raised
- Undisclosed
Investors
- 2
About sRNAlytics
sRNAlytics is a biotechnology company focused on pioneering precision therapeutics that utilize small RNA molecules to address critical health issues.sRNAlytics specializes in the development of therapeutics centered around small RNA technologies. The company was co-founded by David Salzman and Neal Foster.sRNAlytics develops precision therapeutics through its proprietary Code-Breaker™ platform, which utilizes artificial intelligence to dissect the intricate landscape of small RNAs (sRNAs). The company's primary focus is on creating biomarker-guided oligonucleotide therapeutics that target pulmonary, cardiac, neurological, and autoimmune diseases.sRNAlytics operates a revenue model based on partnerships and collaborations with biotech companies and research institutions. These partnerships typically involve co-development agreements where resources and expertise are shared to advance specific therapeutic targets. The company may also benefit from milestone-based payments that are contingent on the progression of clinical trials or regulatory approvals related to products derived from their platform.To support its growth, sRNAlytics plans to expand its product offerings and enter new markets. The company is actively designing new therapeutics aimed at enhancing its Code-Breaker™ platform capabilities. Additionally, sRNAlytics intends to increase its presence in the Asian market by the end of 2024.
Who invested in sRNAlytics
2 investors across 1 round
See all investors in sRNAlytics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 14, 2017
Amount
Undisclosed
Investors
Questions about sRNAlytics
Who invested in sRNAlytics?
sRNAlytics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has sRNAlytics raised?
sRNAlytics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did sRNAlytics last raise money?
sRNAlytics's most recent round on record is a Seed, in Nov 2017.
What does sRNAlytics do?
sRNAlytics is a biotechnology company focused on pioneering precision therapeutics that utilize small RNA molecules to address critical health issues.
Where is sRNAlytics headquartered?
sRNAlytics is headquartered in San Francisco, US.
Which VCs invest in companies like sRNAlytics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at sRNAlytics's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like sRNAlytics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.